Amgen Wins Order Blocking Colorado's Enbrel Price Cap
By Lauren Berg · July 1, 2026, 7:52 PM EDT
Colorado is preliminarily blocked from enforcing its price cap on Amgen's rheumatoid arthritis drug Enbrel, a federal judge ruled Wednesday, saying the biotech company is likely to succeed on its claim...
To view the full article, register now.